Editorial comment on "Dutasteride, a 5 alpha-reductase inhibitor, could be associated with the exacerbation of inflammation in patients with benign prostatic hyperplasia"

Int J Urol. 2025 Jan 15. doi: 10.1111/iju.15631. Online ahead of print.
No abstract available